CN103736085A - 一种预防和治疗老年性痴呆的药物 - Google Patents
一种预防和治疗老年性痴呆的药物 Download PDFInfo
- Publication number
- CN103736085A CN103736085A CN201310732234.0A CN201310732234A CN103736085A CN 103736085 A CN103736085 A CN 103736085A CN 201310732234 A CN201310732234 A CN 201310732234A CN 103736085 A CN103736085 A CN 103736085A
- Authority
- CN
- China
- Prior art keywords
- parts
- alzheimer disease
- radix
- medicament
- theory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 208000024827 Alzheimer disease Diseases 0.000 title claims abstract description 20
- 102000007625 Hirudins Human genes 0.000 claims abstract description 8
- 108010007267 Hirudins Proteins 0.000 claims abstract description 8
- 235000003650 acai Nutrition 0.000 claims abstract description 8
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 229940006607 hirudin Drugs 0.000 claims abstract description 3
- 235000012601 Euterpe oleracea Nutrition 0.000 claims description 7
- 244000207620 Euterpe oleracea Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 235000005903 Dioscorea Nutrition 0.000 claims description 4
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 244000281702 Dioscorea villosa Species 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000004556 brain Anatomy 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 230000004064 dysfunction Effects 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 241000700159 Rattus Species 0.000 description 9
- 229940079593 drug Drugs 0.000 description 6
- 230000002490 cerebral effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000234273 Dioscorea Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 229940122041 Cholinesterase inhibitor Drugs 0.000 description 2
- 239000000544 cholinesterase inhibitor Substances 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 230000002536 noncholinergic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 description 1
- 238000012347 Morris Water Maze Methods 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 1
- ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000133430 Tinospora Species 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940108366 exelon Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical group N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000002763 pyramidal cell Anatomy 0.000 description 1
- ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310732234.0A CN103736085B (zh) | 2013-12-27 | 2013-12-27 | 一种预防和治疗老年性痴呆的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310732234.0A CN103736085B (zh) | 2013-12-27 | 2013-12-27 | 一种预防和治疗老年性痴呆的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103736085A true CN103736085A (zh) | 2014-04-23 |
CN103736085B CN103736085B (zh) | 2015-07-29 |
Family
ID=50493200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310732234.0A Expired - Fee Related CN103736085B (zh) | 2013-12-27 | 2013-12-27 | 一种预防和治疗老年性痴呆的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103736085B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177046A (zh) * | 2016-08-29 | 2016-12-07 | 杨添福 | 一种基于普立宁钾开发的神经认知障碍治疗药物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1791418A (zh) * | 2003-03-21 | 2006-06-21 | K2A公司 | Jucara和acai果实基营养补充剂 |
CN101314004A (zh) * | 2007-05-29 | 2008-12-03 | 北京羚锐伟业科技有限公司 | 一种治疗妇科泌尿系统感染的药物及其制备方法 |
-
2013
- 2013-12-27 CN CN201310732234.0A patent/CN103736085B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1791418A (zh) * | 2003-03-21 | 2006-06-21 | K2A公司 | Jucara和acai果实基营养补充剂 |
CN101314004A (zh) * | 2007-05-29 | 2008-12-03 | 北京羚锐伟业科技有限公司 | 一种治疗妇科泌尿系统感染的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
DE-QIANG LI ET AL.: "Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer"s Disease: A 20-Week Open-Label Pilot Study", 《INTERNATIONAL JOURNAL OF MEDICAL SCIENCES》 * |
胡增峣等: "中药复方治疗老年痴呆的用药规律分析", 《中药药理与临床》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177046A (zh) * | 2016-08-29 | 2016-12-07 | 杨添福 | 一种基于普立宁钾开发的神经认知障碍治疗药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103736085B (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101181600B (zh) | 用于治疗心脑血管疾病的中药组合物 | |
CN101168029B (zh) | 舒肝理气解毒胶囊的制作方法 | |
CN102657711B (zh) | 一种治疗脑中风的药物及其制备方法 | |
CN107744571B (zh) | 一种改善血管内皮功能障碍的药物组合物及其制备方法和用途 | |
CN103417877A (zh) | 用草药治癌防癌 | |
CN103736085A (zh) | 一种预防和治疗老年性痴呆的药物 | |
CN105456924A (zh) | 含有艾叶的具有活血化瘀功能的中药制剂及其制备方法 | |
CN105435196A (zh) | 一种治疗气滞血瘀型冠心病心绞痛并患有慢性胃炎的外用中药药膏及其制备方法 | |
CN102114211B (zh) | 一种治疗肝炎的中草药 | |
CN105749216A (zh) | 一种治疗高血压的中药酒及其制备方法 | |
CN102397363A (zh) | 一种治疗高血压的中药 | |
CN104740054A (zh) | 一种防治心肌缺血的药物组合物及其制备方法和用途 | |
CN116211945B (zh) | 一种中药组合物及其制备方法与在制备用于治疗或预防慢性脑供血不足的药物中的应用 | |
CN103301429B (zh) | 治疗妇女痛经的口服制剂 | |
CN111773292B (zh) | 一种治疗带状疱疹的中药组合物、制备方法及其应用 | |
CN110215474B (zh) | 一种活血化瘀中药组合物及其应用 | |
CN102631421A (zh) | 一种治疗老年痴呆病的中药 | |
CN102225154B (zh) | 一种治疗肺纤维化的药物组合物 | |
CN101983712A (zh) | 冠心病的新型治疗药物 | |
CN106880672A (zh) | 一种中药组合物 | |
CN105983053B (zh) | 一种治疗心脑血管疾病的中药组合及其制备 | |
CN105031108A (zh) | 一种治疗慢性萎缩性脊髓侧索硬化症的药物 | |
CN105770339A (zh) | 一种用于治疗痤疮的药物 | |
CN105079687A (zh) | 一种治疗动脉瘤的药物组合物及其制备方法和用途 | |
CN102258554A (zh) | 一种治疗老年痴呆的新药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yaping Inventor before: Huang Yongge |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170913 Address after: 037000 Shanxi Province, Datong City, garden 1 Building 2 unit 6 Patentee after: Zhang Yaping Address before: Nanning city 530003 the Guangxi Zhuang Autonomous Region Qingxiu District Green Road No. 86 Dream Island Garden 3-1-903 Patentee before: Nanning Pindi Biological Engineering Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150729 Termination date: 20171227 |
|
CF01 | Termination of patent right due to non-payment of annual fee |